Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation
Resumen: MMACHC protein plays a crucial role in the metabolism of vitamin B12 (cobalamin, Cbl) by catalyzing its conversion into the active forms adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl), which serve as essential cofactors in key cellular reactions. Mutations in the gene encoding MMACHC lead to the rare metabolic disorder known as methylmalonic aciduria and homocystinuria, cblC type. This condition predominantly affects children and is characterized by cardiovascular dysfunction, intellectual disability, and a severe form of maculopathy. The most common missense mutation, R161Q, impairs enzymatic activity despite not being directly involved in cobalamin binding. Here, using a comprehensive set of biophysical techniques, we demonstrate that this pathogenic variant compromises MMACHC structural stability, alters the thermal unfolding cooperativity and pathway, as well as the populations of conformational intermediates. Moreover, we show that the R161Q mutation decreases AdoCbl binding affinity and impairs the protein's ability to form homodimers, which are supposed to have a functional role. A partial recovery in protein activity upon treatment with betaine, an osmolyte known for its stabilizing effect on proteins, was observed. This suggests a direct correlation between the energetics of MMACHC thermal unfolding and its functional activity. These findings contribute to a deeper understanding of the molecular mechanisms underlying MMACHC function and open avenues for potential therapeutic interventions.
Idioma: Inglés
DOI: 10.1016/j.ymgme.2025.109150
Año: 2025
Publicado en: Molecular genetics and metabolism 145, 3 (2025), 109150 [14 pp.]
ISSN: 1096-7192

Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.


Exportado de SIDERAL (2025-10-17-14:14:09)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos > Artículos por área > Bioquímica y Biología Molecular



 Registro creado el 2025-06-12, última modificación el 2025-10-17


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)